Xiaoyang Xia;Hitchcock Stephen;Albert Amegadzie;Scott S. Harried;Wenyuan Qian
发明人:
Hitchcock Stephen,Albert Amegadzie,Wenyuan Qian,Xiaoyang Xia,Scott S. Harried
申请号：
US13426539
公开号：
US08735383B2
申请日:
2012.03.21
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides compounds that are glycine transporter 1 (hereinafter referred to as GlyT-1) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of GlyT-1 such as cognitive disorders associated with Schizophrenia, ADHD (attention deficit hyperactivity disorder), MCI (mild cognitive impairment), and the like. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
